Collectively, these findings indicate that decreased Arc, Bdnf and Reln expressions in the hippocampus are medicated by promoter hypermethylation, which is involved in the upstream mechanisms for sevoflurane induced cognitive impairment in aged rats. The gene discussed is ARC; the disease is Cognitive impairment.